Tag: Cancer: Uterine
Use of Minimally Invasive Sx for Endometrial Cancer Varies
Minimally invasive surgery less likely for patients with Medicaid; for blacks, Hispanics versus whites
Ovarian Conservation Safe in Endometrial Cancer, but Use Low
Findings among premenopausal women undergoing hysterectomy
Doctors Rally in Support of Morcellator Use Curbed by FDA
Agency overstated odds of power morcellator spreading cancer, review group says
Robotic Surgery May Be Superior to Laparoscopic for Uterine CA
Robotic is more costly, but results in shorter length of stay and greater rate of lymph node dissection
Minimally Invasive Hysterectomy May Be Underused
Racial disparities associated with use of the procedure for uterine, cervical cancers
Incidence of Endometrial Cancer on the Rise Across Racial Groups
Non-Hispanic black women have higher incidence and lower survival across all stages and subtypes
ASCO Endorses ASTRO Guidelines for Endometrial Cancer
Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases
Robotic Sx Viable for Morbidly Obese With Endometrial Cancer
No differences in blood loss, complication rates, survival for morbidly obese, lower-weight patients
Mediterranean Diet Might Lower Endometrial Cancer Risk
Women who followed it most closely saw significant reduction in risk
Cancer Prevalence Low in Power Morcellation Fibroid Removal
Researchers call the findings 'reassuring,' but FDA warnings remain for older women
